Regenxbio
RGNX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Regenxbio(RGNX) predict that the Revenue is 6.393 M (-92.82%), Miss estimate;the EBIT is -83.36 M (-787.4%), Miss estimate;the EPS is -1.72 (-1533%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.01B92.82%
0.03B71.64%
-0.02B21.18%
EBITMiss expectations
-0.08B787.41%
-0.06B635.75%
-0.02B151.66%
EPSMiss expectations
-1.721533.33%
-1.30141184.53%
-0.4186348.80%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf